SPY303.61+0.64 0.21%
DIA254.12-0.23 -0.09%
IXIC9,454.32+85.33 0.91%

Acceleron Pharma Q1 Net Loss $50.9M, Sales $4.300M Miss $5.260M Estimate

Acceleron Pharma (NASDAQ:XLRN) reported quarterly sales of $4.300 million which missed the analyst consensus estimate of $5.260 million by 18.25 percent. This is a 54.68 percent increase over sales of $2.780 million the

Benzinga · 05/11/2020 20:32

Acceleron Pharma (NASDAQ:XLRN) reported quarterly sales of $4.300 million which missed the analyst consensus estimate of $5.260 million by 18.25 percent. This is a 54.68 percent increase over sales of $2.780 million the same period last year.